New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

Table of Contents

0 Table of Contents

1 Home

2 Artifacts Summary

2.1 Clinical coding system code

2.2 Clinical code type code

2.3 Admission type code

2.4 99NZREL-Relationship

2.5 AIR vaccine product

2.6 Smoking status

2.7 Admission source code

2.8 DSM-IV

2.9 Health service type refset vs

2.10 Coverage Type

2.11 AIR status reason code

2.12 NZ ethnic group code level 4

2.13 Agency type code

2.14 AIR route of administration

2.15 AIR vaccinator function

2.16 NZ Residency Information Source

2.17 Antiviral eligibility symptoms started

2.18 Ethnicity of a person (full)

2.19 Māori descent codes

2.20 Rheumatic fever care plan category

2.21 Rheumatic fever care team participant role

2.22 Rheumatic fever diagnostic certainty

2.23 Rheumatic fever medication allergy

2.24 Rheumatic fever rheumatic heart disease severity

2.25 NZPS Observation Vaping Status

2.26 Absent or Unknown Allergies - IPS

2.27 Absent or Unknown Devices - IPS

2.28 Absent or Unknown Immunization - IPS

2.29 Absent or Unknown Medication - IPS

2.30 Absent or Unknown Problems - IPS

2.31 Absent or Unknown Procedures - IPS

2.32 AdministrativeGender

2.33 AdverseEventSeverity

2.34 AllergyIntoleranceCategory

2.35 AllergyIntoleranceCriticality

2.36 Allergy Intolerance Substance Condition - IPS

2.37 AllergyIntoleranceType

2.38 Allergy Intolerance - IPS

2.39 Allergy Reaction - SNOMED CT IPS Free Set

2.40 ANZSCO

2.41 Body Site - IPS

2.42 ISO 639-3 language codes

2.43 NZ AJCC 8th edition residual tumour category clinical

2.44 NZ AJCC (8th edition) edition residual tumour category

2.45 NZ cancer acute leukaemia cancer type

2.46 NZ cancer adjacent organ invasion

2.47 NZ AJCC cancer staging manual edition

2.48 NZ cancer Ann Arbor lymphoma stage

2.49 NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type

2.50 NZ cancer B cell lymphoid cancer type

2.51 NZ cancer B cell lymphoma cancer type

2.52 NZ cancer basis of diagnosis

2.53 NZ cancer Binet staging for CLL stage

2.54 NZ cancer BL-IPI prognostic score

2.55 NZ cancer bone cancer type

2.56 NZ cancer bone other topography

2.57 NZ cancer breast nipple-areola complex topography

2.58 NZ cancer colorectal metastectomy topography

2.59 NZ cancer PCR OR NGS test method

2.60 NZ cancer gastrointestinal colorectal specimen collection procedure

2.61 NZ cancer gastrointestinal colorectal endoscopic resection specimen collection procedure

2.62 NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure

2.63 NZ cancer gastrointestinal colorectal operative resection specimen collection procedure

2.64 NZ cancer service

2.65 NZ cancer stream

2.66 NZ cancer substream

2.67 New Zealand cancer colorectal colonoscopy topography

2.68 NZ cancer type

2.69 NZ cancer central nervous system brain topography

2.70 NZ cancer CNS cancer type

2.71 NZ cancer CNS-IPI for large B cell lymphoma prognostic score

2.72 NZ cancer central nervous system meninges topography

2.73 NZ cancer central nervous system nerve topography

2.74 NZ cancer central nervous system other topography

2.75 NZ cancer central nervous system spinal cord topography

2.76 NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score

2.77 NZ cancer central nervous system topography

2.78 NZ cancer colorectal cancer type

2.79 NZ perforation present in colon

2.80 NZ cancer completion status

2.81 NZ cancer data absent reason

2.82 NZ cancer detected result

2.83 NZ cancer DIPSS+ for myelofibrosis prognostic score

2.84 NZ cancer ECOG status

2.85 NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score

2.86 NZ cancer endocrine cancer type

2.87 NZ cancer endocrine and/or neuroendocrine cancer type

2.88 NZ cancer endocrine and/or neuroendocrine substream

2.89 NZ cancer ER expression

2.90 NZ cancer EUTOS for CML prognostic score

2.91 NZ cancer eye and/or orbit cancer type

2.92 NZ cancer eye and/or orbit conjunctiva topography

2.93 NZ cancer eye and/or orbit eyelid topography

2.94 NZ cancer eye and/or orbit lacrimal drainage system topography

2.95 NZ cancer eye and/or orbit lacrimal gland topography

2.96 NZ cancer eye and/or orbit lens topography

2.97 NZ cancer eye and/or orbit other topography

2.98 NZ cancer eye and/or orbit retina topography

2.99 NZ cancer eye and/or orbit sclera topography

2.100 NZ cancer eye and/or orbit topography

2.101 NZ cancer eye and/or orbit uveal tract topography

2.102 NZ cancer female genital cervix uteri topography

2.103 NZ cancer female genital corpus uteri topography

2.104 NZ cancer female genital fallopian tube topography

2.105 NZ cancer female genital gestational trophoblastic disease topography

2.106 NZ cancer female genital ovary topography

2.107 NZ cancer female genital peritoneum topography

2.108 NZ cancer female genital topography

2.109 NZ cancer female genital uterine ligament topography

2.110 NZ cancer female genital vagina topography

2.111 NZ cancer female genital vulva topography

2.112 NZ cancer FIGO 2001 gestational trophoblastic disease stage

2.113 NZ cancer FIGO 2009 endometrial carcinoma grade

2.114 NZ cancer FIGO 2014 ovary and/or fallopian tube and/or primary peritoneal carcinoma stage

2.115 NZ cancer FIGO 2018 cervix uteri stage

2.116 NZ cancer FIGO 2018 vagina stage

2.117 NZ cancer FIGO 2021 vulva stage

2.118 NZ cancer FLIPI prognostic score

2.119 NZ cancer follicular lymphoma grade

2.120 NZ cancer gastrointestinal cancer type

2.121 NZ cancer gastrointestinal substream

2.122 NZ cancer genitourinary cancer type

2.123 NZ cancer genitourinary SACT cancer type

2.124 NZ cancer genitourinary substream

2.125 NZ cancer GHSG Hodgkin treatment stratification stage

2.126 NZ cancer gastrointestinal anus topography

2.127 NZ cancer gastrointestinal appendix topography

2.128 NZ cancer gastrointestinal biliary topography

2.129 NZ cancer gastrointestinal colorectal topography

2.130 NZ cancer gastrointestinal duodenum topography

2.131 NZ cancer gastrointestinal endocrine pancreas topography

2.132 NZ cancer gastrointestinal exocrine pancreas topography

2.133 NZ cancer gastrointestinal ileum and/or jejunum topography

2.134 NZ cancer gastrointestinal liver topography

2.135 NZ cancer lower gastrointestinal topography

2.136 NZ cancer gastrointestinal oesophagus topography

2.137 NZ cancer gastrointestinal pancreas topography

2.138 NZ cancer gastrointestinal rectum topography

2.139 NZ cancer gastrointestinal small intestine topography

2.140 NZ cancer gastrointestinal stomach topography

2.141 NZ cancer gastrointestinal topography

2.142 NZ cancer upper gastrointestinal topography

2.143 NZ cancer gynaecological cancer type

2.144 NZ cancer gynaecological SACT cancer type

2.145 NZ cancer haematology prognostic scoring system

2.146 NZ cancer haematology staging system

2.147 NZ cancer haematology stream

2.148 NZ cancer haematology substream

2.149 NZ cancer haematology treatment intent

2.150 NZ cancer other head and neck cancer type

2.151 NZ cancer head and neck substream

2.152 NZ cancer hepatopancreaticobiliary cancer type

2.153 NZ cancer HER2 expression

2.154 NZ cancer high level topography

2.155 NZ histiocytic cancer type

2.156 NZ cancer IELSG (International Extranodal Lymphoma Study Group) prognostic score

2.157 NZ cancer International Prognostic Score for thrombosis in ET prognostic score

2.158 NZ cancer IPSS-M for MDS prognostic score

2.159 NZ cancer IPSS-R for MDS prognostic score

2.160 NZ cancer IPSS for Waldenstrom Macroglobulinemia prognostic score

2.161 NZ cancer body landmark

2.162 NZ cancer lateralisable topography

2.163 NZ cancer laterality mandatory

2.164 NZ cancer laterality optional

2.165 NZ cancer laterality or side

2.166 NZ cancer laterality

2.167 NZ cancer leukaemia cancer type

2.168 NZ cancer leukaemia substream

2.169 NZ cancer breast lymph node

2.170 NZ cancer gastrointestinal colorectal lymph node

2.171 NZ cancer gastrointestinal lymph node

2.172 NZ cancer thorax lung lymph node

2.173 NZ cancer thorax lymph node

2.174 NZ cancer lymph node

2.175 NZ cancer lymphoma cancer type

2.176 NZ cancer lymphoma substream

2.177 NZ cancer male genital other topography

2.178 NZ cancer male genital SACT cancer type

2.179 NZ cancer male genital topography

2.180 NZ cancer mastocytosis cancer type

2.181 NZ cancer mature T/NK cell lymphoid cancer type

2.182 NZ cancer Mayo staging for AL (amyloidosis) stage

2.183 NZ cancer MD Anderson residual cancer burden

2.184 NZ cancer myelodysplastic-myeloproliferative cancer type

2.185 NZ cancer melanoma cancer type

2.186 NZ cancer midline topography

2.187 NZ cancer MIPI prognostic score

2.188 NZ cancer medical oncology treatment intent

2.189 NZ cancer modified Ryan tumour regression score

2.190 New Zealand cancer colorectal colonoscopy 2 week referral criteria

2.191 New Zealand cancer colorectal colonoscopy 6 week referral criteria

2.192 NZ cancer myeloid proliferation and/or myeloid neoplasm cancer type

2.193 NZ cancer myeloproliferative cancer type

2.194 NZ cancer nasal cavity and paranasal sinus cancer type

2.195 NZ cancer neoadjuvant therapy response system

2.196 NZ cancer neoadjuvant therapy administration type

2.197 NZ cancer neuroendocrine cancer type

2.198 NZ cancer neuroendocrine GEP cancer type

2.199 NZ cancer neuroendocrine non GEP cancer type

2.200 NZ cancer neuroendocrine substream

2.201 NZ cancer NK/T cell non Hodgkin lymphoma treatment stratification stage

2.202 NZ cancer non Hodgkin lymphoma cancer type

2.203 NZ cancer genitourinary (non prostate) cancer type

2.204 NZ cancer not performed reason

2.205 NZ Nottingham Combined grade

2.206 NZ cancer nuclear grade of DCIS grade

2.207 NZ cancer observation code

2.208 NZ cancer orbit topography

2.209 NZ cancer performance status

2.210 NZ cancer pharynx and larynx and trachea cancer type

2.211 NZ cancer PIT prognostic score

2.212 NZ cancer plasma cell cancer type

2.213 NZ cancer PR expression

2.214 NZ cancer presence of tumour finding

2.215 NZ cancer primary topography

2.216 NZ cancer procedure

2.217 NZ cancer prognostic scoring system

2.218 NZ cancer Rai staging for CLL stage

2.219 NZ cancer recurrence type

2.220 NZ cancer referral pathway simple

2.221 NZ cancer R-ISS for multiple myeloma stage

2.222 NZ SACT acute lymphoblastic leukemia disease response

2.223 NZ SACT acute myeloid leukemia disease response

2.224 NZ SACT amyloidosis disease response

2.225 NZ SACT basis of diagnosis

2.226 NZ SACT cancer type

2.227 NZ SACT chronic lymphocytic leukemia and/or small lymphocytic lymphoma disease response

2.228 NZ SACT chronic myeloid leukemia disease response

2.229 NZ SACT dose adjustment reason

2.230 NZ SACT dose form

2.231 NZ SACT dose unit

2.232 NZ SACT ER expression

2.233 NZ SACT HER2 expression

2.234 NZ SACT myelodysplastic syndrome disease response

2.235 NZ SACT medical oncology disease response

2.236 NZ SACT myleoma disease response

2.237 NZ SACT lymphoma (non small lymphocytic) disease response

2.238 NZ SACT overall discontinue reason

2.239 NZ SACT patient factor discontinue

2.240 NZ SACT PR expression

2.241 NZ SACT regimen code

2.242 NZ SACT route of administration

2.243 NZ systemic anti-cancer therapy toxicity discontinue reason

2.244 NZ cancer side mandatory

2.245 NZ cancer side optional

2.246 NZ cancer skin cancer type

2.247 NZ cancer skin and/or melanoma cancer type

2.248 NZ cancer skin and/or melanoma substream

2.249 NZ cancer skin topography

2.250 NZ cancer soft tissue and/or bone cancer type

2.251 NZ cancer soft tissue and/or bone substream

2.252 NZ cancer soft tissue cancer type

2.253 NZ cancer Sokal index for CML prognostic score

2.254 NZ cancer solid tumour stream

2.255 NZ cancer solid tumour grading system

2.256 NZ cancer solid tumour SACT cancer type

2.257 NZ cancer solid tumour staging system

2.258 NZ cancer solid tumour substream

2.259 NZ cancer spread type

2.260 NZ cancer staging system

2.261 NZ cancer T/NK cell lymphoid cancer type

2.262 NZ cancer T/NK cell lymphoma cancer type

2.263 NZ cancer test failure reason

2.264 NZ cancer test inconclusive reason

2.265 NZ cancer thoracic cancer type

2.266 NZ cancer thorax lung topography

2.267 NZ cancer thorax pericardium topography

2.268 NZ cancer thorax pleura topography

2.269 NZ cancer thorax soft tissue topography

2.270 NZ cancer thorax thymus topography

2.271 NZ cancer thorax topography

2.272 NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage

2.273 NZ AJCC breast clinical M category

2.274 NZ AJCC breast clinical T category

2.275 NZ AJCC breast pathological N category

2.276 NZ AJCC breast pathological T category

2.277 NZ AJCC breast stage group

2.278 NZ AJCC clinical stage group

2.279 NZ AJCC clinical M category

2.280 NZ AJCC clinical N category

2.281 NZ AJCC clinical T category

2.282 NZ AJCC female genital corpus uteri adenosarcoma stage group

2.283 NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma stage group

2.284 NZ AJCC female genital cervix uteri clinical M category

2.285 NZ AJCC female genital cervix uteri clinical N category

2.286 NZ AJCC female genital cervix uteri clinical T category

2.287 NZ AJCC female genital cervix uteri pathological M category

2.288 NZ AJCC female genital cervix uteri pathological N category

2.289 NZ AJCC female genital cervix uteri pathological T category

2.290 NZ AJCC female genital cervix uteri stage group

2.291 NZ AJCC female genital clinical M category

2.292 NZ AJCC female genital clinical N category

2.293 NZ AJCC female genital corpus uteri adenosarcoma clinical T category

2.294 NZ AJCC female genital corpus uteri adenosarcoma pathological N category

2.295 NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma clinical N category

2.296 NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma clinical T category

2.297 NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma pathological N category

2.298 NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma pathological T category

2.299 NZ AJCC female genital corpus uteri clinical M category

2.300 NZ AJCC female genital corpus uteri clinical N category

2.301 NZ AJCC female genital corpus uteri clinical T category

2.302 NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma clinical N category

2.303 NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma clinical T category

2.304 NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma pathological N category

2.305 NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma pathological T category

2.306 NZ AJCC female genital corpus uteri pathological M category

2.307 NZ AJCC female genital corpus uteri pathological N category

2.308 NZ AJCC female genital corpus uteri pathological T category

2.309 NZ AJCC female genital corpus uteri stage group

2.310 NZ AJCC female genital gestational trophoblastic disease clinical M category

2.311 NZ AJCC female genital gestational trophoblastic disease clinical T category

2.312 NZ AJCC female genital gestational trophoblastic disease pathological M category

2.313 NZ AJCC female genital gestational trophoblastic disease pathological T category

2.314 NZ AJCC female genital gestational trophoblastic disease stage group

2.315 NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma clinical M category

2.316 NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma clinical T category

2.317 NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological M category

2.318 NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological N category

2.319 NZ AJCC female genital pathological N category

2.320 NZ AJCC female genital pathological T category

2.321 NZ AJCC female genital stage group

2.322 NZ AJCC female genital vagina clinical M category

2.323 NZ AJCC female genital vagina clinical N category

2.324 NZ AJCC female genital vagina clinical T category

2.325 NZ AJCC female genital vagina pathological M category

2.326 NZ AJCC female genital vagina pathological N category

2.327 NZ AJCC female genital vagina pathological T category

2.328 NZ AJCC female genital vulva clinical M category

2.329 NZ AJCC female genital vulva clinical N category

2.330 NZ AJCC female genital vulva clinical T category

2.331 NZ AJCC female genital vulva pathological M category

2.332 NZ AJCC female genital vulva pathological N category

2.333 NZ AJCC female genital vulva pathological T category

2.334 NZ AJCC female genital vulva stage group

2.335 NZ AJCC gastrointestinal clinical M category

2.336 NZ AJCC gastrointestinal colon and/or rectum clinical M category

2.337 NZ AJCC gastrointestinal colon and/or rectum clinical N category

2.338 NZ AJCC gastrointestinal colon and/or rectum clinical T category

2.339 NZ AJCC gastrointestinal colon and/or rectum pathological M category

2.340 NZ AJCC gastrointestinal colon and/or rectum pathological N category

2.341 NZ AJCC gastrointestinal colon and/or rectum pathological T category

2.342 NZ AJCC gastrointestinal colon and/or rectum stage group

2.343 NZ AJCC gastrointestinal clinical T category

2.344 NZ AJCC gastrointestinal pathological stage group

2.345 NZ AJCC gastrointestinal pathological M category

2.346 NZ AJCC gastrointestinal pathological T category

2.347 NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group

2.348 NZ AJCC gastrointestinal stromal tumour clinical M category

2.349 NZ AJCC gastrointestinal stromal tumour clinical T category

2.350 NZ AJCC gastrointestinal stromal tumour gastric and/or omental stage group

2.351 NZ AJCC gastrointestinal stromal tumour small intestine and/or oesophageal and/or colon and/or rectum and/or mesenteric and/or peritoneal stage group

2.352 NZ AJCC gastrointestinal stromal tumour pathological M category

2.353 NZ AJCC gastrointestinal stromal tumour pathological N category

2.354 NZ AJCC gastrointestinal stromal tumour pathological T category

2.355 NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group

2.356 NZ AJCC haematology clinical M category

2.357 NZ AJCC haematology clinical N category

2.358 NZ AJCC haematology clinical T category

2.359 NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group

2.360 NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category

2.361 NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N category

2.362 NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T category

2.363 NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N category

2.364 NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T category

2.365 NZ AJCC haematology mycosis fungoides or sezary syndrome stage group

2.366 NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category

2.367 NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical N category

2.368 NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M category

2.369 NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological N category

2.370 NZ AJCC haematology pediatric Hodgkin lymphoma stage group

2.371 NZ AJCC haematology pediatric non-Hodgkin lymphoma stage group

2.372 NZ AJCC haematology plasma cell myeloma stage group

2.373 NZ AJCC haematology pathological T category

2.374 NZ AJCC haematology stage group

2.375 NZ AJCC neuroendocrine gastrointestinal clinical N category

2.376 NZ AJCC neuroendocrine gastrointestinal colon and/or rectum clinical M category

2.377 NZ AJCC neuroendocrine gastrointestinal colon and/or rectum clinical N category

2.378 NZ AJCC neuroendocrine gastrointestinal colon and/or rectum clinical T category

2.379 NZ AJCC neuroendocrine gastrointestinal colon and/or rectum pathological M category

2.380 NZ AJCC neuroendocrine gastrointestinal colon and/or rectum pathological N category

2.381 NZ AJCC neuroendocrine gastrointestinal colon and/or rectum pathological T category

2.382 NZ AJCC neuroendocrine gastrointestinal clinical T category

2.383 NZ AJCC neuroendocrine gastrointestinal pathological M category

2.384 NZ AJCC neuroendocrine gastrointestinal pathological N category

2.385 NZ AJCC neuroendocrine gastrointestinal pathological T category

2.386 NZ AJCC neuroendocrine gastrointestinal stage group

2.387 NZ AJCC pathological stage group

2.388 NZ AJCC pathological M category

2.389 NZ AJCC pathological N category

2.390 NZ TNM post surgery classification

2.391 NZ AJCC pathological T category

2.392 NZ AJCC recurrence or retreatment clinical N category (rcN)

2.393 NZ AJCC recurrence or retreatment clinical T category (rcT)

2.394 NZ AJCC recurrence or retreatment pathological M category (rpM)

2.395 NZ AJCC recurrence or retreatment pathological N category (rpN)

2.396 NZ AJCC recurrence or retreatment pathological T category (rpT)

2.397 NZ TNM stage classification

2.398 NZ AJCC thoracic clinical M category

2.399 NZ AJCC thoracic clinical N category

2.400 NZ AJCC thoracic clinical T category

2.401 NZ AJCC thoracic lung clinical M category

2.402 NZ AJCC thoracic lung clinical N category

2.403 NZ AJCC thoracic lung clinical T category

2.404 NZ AJCC thoracic lung pathological M category

2.405 NZ AJCC thoracic lung pathological N category

2.406 NZ AJCC thoracic lung pathological T category

2.407 NZ AJCC thoracic malignant pleural mesothelioma clinical N category

2.408 NZ AJCC thoracic malignant pleural mesothelioma clinical T category

2.409 NZ AJCC thoracic malignant pleural mesothelioma pathological M category

2.410 NZ AJCC thoracic malignant pleural mesothelioma pathological N category

2.411 NZ AJCC thoracic malignant pleural mesothelioma stage group

2.412 NZ AJCC thoracic pathological M category

2.413 NZ AJCC thoracic pathological N category

2.414 NZ AJCC thoracic pathological T category

2.415 NZ AJCC thoracic stage group

2.416 NZ AJCC thoracic thymus clinical M category

2.417 NZ AJCC thoracic thymus clinical N category

2.418 NZ AJCC thoracic thymus clinical T category

2.419 NZ AJCC thoracic thymus pathological M category

2.420 NZ AJCC thoracic thymus pathological N category

2.421 NZ AJCC thoracic thymus pathological T category

2.422 NZ AJCC post therapy (neoadjuvant) clinical T category (ycT)

2.423 NZ AJCC post therapy (neoadjuvant) pathological stage group

2.424 NZ AJCC post therapy (neoadjuvant) pathological N category (ypN)

2.425 NZ AJCC post therapy (neoadjuvant) pathological T category (ypT)

2.426 NZ AJCC (8th edition) breast clinical stage group

2.427 NZ AJCC (8th edition) breast clinical N category

2.428 NZ AJCC (8th edition) breast clinical T category

2.429 NZ AJCC (8th edition) breast pathological stage group

2.430 NZ AJCC (8th edition) breast pathological M category

2.431 NZ AJCC (8th edition) breast pathological N category

2.432 NZ AJCC (8th edition) breast pathological T category

2.433 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma stage group

2.434 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma stage group

2.435 NZ AJCC (8th edition) female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma stage group

2.436 NZ AJCC (8th edition) female genital cervix uteri clinical M category

2.437 NZ AJCC (8th edition) female genital cervix uteri clinical T category

2.438 NZ AJCC (8th edition) female genital cervix uteri pathological M category

2.439 NZ AJCC (8th edition) female genital cervix uteri pathological N category

2.440 NZ AJCC (8th edition) female genital cervix uteri pathological T category

2.441 NZ AJCC (8th edition) female genital cervix uteri stage group

2.442 NZ AJCC (8th edition) female genital clinical M category

2.443 NZ AJCC (8th edition) female genital clinical N category

2.444 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical N category

2.445 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T category

2.446 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological N category

2.447 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T category

2.448 NZ AJCC (8th edition) female genital corpus uteri carcinoma and/or carcinosarcoma clinical N category

2.449 NZ AJCC (8th edition) female genital corpus uteri carcinoma and/or carcinosarcoma pathological N category

2.450 NZ AJCC (8th edition) female genital corpus uteri carcinoma and/or carcinosarcoma pathological T category

2.451 NZ AJCC (8th edition) female genital corpus uteri carcinoma and/or carcinosarcoma stage group

2.452 NZ AJCC (8th edition) female genital corpus uteri clinical M category

2.453 NZ AJCC (8th edition) female genital corpus uteri clinical N category

2.454 NZ AJCC (8th edition) female genital corpus uteri clinical T category

2.455 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma clinical N category

2.456 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma clinical T category

2.457 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma pathological T category

2.458 NZ AJCC (8th edition) female genital corpus uteri pathological M category

2.459 NZ AJCC (8th edition) female genital corpus uteri pathological N category

2.460 NZ AJCC (8th edition) female genital corpus uteri pathological T category

2.461 NZ AJCC (8th edition) female genital clinical T category

2.462 NZ AJCC (8th edition) female genital gestational trophoblastic disease clinical M category

2.463 NZ AJCC (8th edition) female genital gestational trophoblastic disease clinical T category

2.464 NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M category

2.465 NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological T category

2.466 NZ AJCC (8th edition) female genital gestational trophoblastic disease stage group

2.467 NZ AJCC (8th edition) female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma clinical M category

2.468 NZ AJCC (8th edition) female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma clinical N category

2.469 NZ AJCC (8th edition) female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological M category

2.470 NZ AJCC (8th edition) female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological N category

2.471 NZ AJCC (8th edition) female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological T category

2.472 NZ AJCC (8th edition) female genital pathological M category

2.473 NZ AJCC (8th edition) female genital pathological N category

2.474 NZ AJCC (8th edition) female genital pathological T category

2.475 NZ AJCC (8th edition) female genital stage group

2.476 NZ AJCC (8th edition) female genital vagina clinical M category

2.477 NZ AJCC (8th edition) female genital vagina clinical T category

2.478 NZ AJCC (8th edition) female genital vagina pathological M category

2.479 NZ AJCC (8th edition) female genital vagina pathological T category

2.480 NZ AJCC (8th edition) female genital vulva clinical M category

2.481 NZ AJCC (8th edition) female genital vulva clinical N category

2.482 NZ AJCC (8th edition) female genital vulva clinical T category

2.483 NZ AJCC (8th edition) female genital vulva pathological M category

2.484 NZ AJCC (8th edition) female genital vulva pathological N category

2.485 NZ AJCC (8th edition) female genital vulva pathological T category

2.486 NZ AJCC (8th edition) female genital vulva stage group

2.487 NZ AJCC (8th edition) gastrointestinal clinical stage group

2.488 NZ AJCC (8th edition) gastrointestinal clinical M category

2.489 NZ AJCC (8th edition) gastrointestinal clinical N category

2.490 NZ AJCC (8th edition) gastrointestinal colon and/or rectum clinical M category

2.491 NZ AJCC (8th edition) gastrointestinal colon and/or rectum clinical N category

2.492 NZ AJCC (8th edition) gastrointestinal colon and/or rectum clinical T category

2.493 NZ AJCC (8th edition) gastrointestinal colon and/or rectum pathological M category

2.494 NZ AJCC (8th edition) gastrointestinal colon and/or rectum pathological N category

2.495 NZ AJCC (8th edition) gastrointestinal colon and/or rectum pathological T category

2.496 NZ AJCC (8th edition) gastrointestinal clinical T category

2.497 NZ AJCC (8th edition) gastrointestinal pathological stage group

2.498 NZ AJCC (8th edition) gastrointestinal pathological N category

2.499 NZ AJCC (8th edition) gastrointestinal pathological T category

2.500 NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group

2.501 NZ AJCC (8th edition) gastrointestinal stromal tumour clinical M category

2.502 NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category

2.503 NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category

2.504 NZ AJCC (8th edition) gastrointestinal stromal tumour gastric and/or omental stage group

2.505 NZ AJCC (8th edition) gastrointestinal stromal tumour small intestine and/or oesophageal and/or colon and/or rectum and/or mesenteric and/or peritoneal stage group

2.506 NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category

2.507 NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category

2.508 NZ AJCC (8th edition) haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group

2.509 NZ AJCC (8th edition) haematology clinical M category

2.510 NZ AJCC (8th edition) haematology clinical N category

2.511 NZ AJCC (8th edition) haematology clinical T category

2.512 NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group

2.513 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category

2.514 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category

2.515 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category

2.516 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category

2.517 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category

2.518 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome stage group

2.519 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category

2.520 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category

2.521 NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category

2.522 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological N category

2.523 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category

2.524 NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group

2.525 NZ AJCC (8th edition) haematology pediatric non Hodgkin lymphoma stage group

2.526 NZ AJCC (8th edition) haematology pathological M category

2.527 NZ AJCC (8th edition) haematology pathological N category

2.528 NZ AJCC (8th edition) haematology pathological T category

2.529 NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical M category

2.530 NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category

2.531 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum clinical M category

2.532 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum clinical N category

2.533 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum clinical T category

2.534 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum pathological M category

2.535 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum pathological N category

2.536 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum pathological T category

2.537 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum stage group

2.538 NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical T category

2.539 NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category

2.540 NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category

2.541 NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category

2.542 NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group

2.543 NZ AJCC (8th edition) thoracic clinical M category

2.544 NZ AJCC (8th edition) thoracic clinical N category

2.545 NZ AJCC (8th edition) thoracic clinical T category

2.546 NZ AJCC (8th edition) thoracic lung clinical M category

2.547 NZ AJCC (8th edition) thoracic lung clinical N category

2.548 NZ AJCC (8th edition) thoracic lung clinical T category

2.549 NZ AJCC (8th edition) thoracic lung pathological M category

2.550 NZ AJCC (8th edition) thoracic lung pathological T category

2.551 NZ AJCC (8th edition) thoracic lung stage group

2.552 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical M category

2.553 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category

2.554 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category

2.555 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological T category

2.556 NZ AJCC (8th edition) thoracic pathological M category

2.557 NZ AJCC (8th edition) thoracic pathological N category

2.558 NZ AJCC (8th edition) thoracic pathological T category

2.559 NZ AJCC (8th edition) thoracic stage group

2.560 NZ AJCC (8th edition) thoracic thymus clinical M category

2.561 NZ AJCC (8th edition) thoracic thymus clinical N category

2.562 NZ AJCC (8th edition) thoracic thymus clinical T category

2.563 NZ AJCC (8th edition) thoracic thymus pathological M category

2.564 NZ AJCC (8th edition) thoracic thymus pathological N category

2.565 NZ AJCC (8th edition) thoracic thymus pathological T category

2.566 NZ AJCC (8th edition) thoracic thymus stage group

2.567 NZ AJCC (9th edition) female genital cervix uteri clinical M category

2.568 NZ AJCC (9th edition) female genital cervix uteri clinical N category

2.569 NZ AJCC (9th edition) female genital cervix uteri clinical T category

2.570 NZ AJCC (9th edition) female genital cervix uteri pathological M category

2.571 NZ AJCC (9th edition) female genital cervix uteri pathological N category

2.572 NZ AJCC (9th edition) female genital cervix uteri pathological T category

2.573 NZ AJCC (9th edition) female genital cervix uteri stage group

2.574 NZ AJCC (9th edition) female genital clinical M category

2.575 NZ AJCC (9th edition) female genital clinical N category

2.576 NZ AJCC (9th edition) female genital clinical T category

2.577 NZ AJCC (9th edition) female genital pathological M category

2.578 NZ AJCC (9th edition) female genital pathological N category

2.579 NZ AJCC (9th edition) female genital pathological T category

2.580 NZ AJCC (9th edition) female genital stage group

2.581 NZ AJCC (9th edition) female genital vulva clinical M category

2.582 NZ AJCC (9th edition) female genital vulva pathological M category

2.583 NZ cancer topography

2.584 NZ cancer treatment intent

2.585 NZ cancer tumour origin

2.586 NZ cancer unknown site topography

2.587 NZ cancer upper gastrointestinal cancer type

2.588 NZ cancer urinary and/or male genital kidney topography

2.589 NZ cancer urinary and/or male genital penis topography

2.590 NZ cancer urinary and/or male genital prostate topography

2.591 NZ cancer urinary and/or male genital renal pelvis and/or ureter topography

2.592 NZ cancer urinary and/or male genital testicular adnexa topography

2.593 NZ cancer urinary and male genital testicular SACT topography

2.594 NZ cancer urinary and/or male genital testis topography

2.595 NZ cancer urinary and/or male genital topography

2.596 NZ cancer urinary and/or male genital urethra topography

2.597 NZ cancer urinary and/or male genital urinary bladder topography

2.598 NZ cancer urinary system topography

2.599 NZ WHO haematolymphoid aggressive B cell lymphoma histology

2.600 NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology

2.601 NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma other histology

2.602 NZ WHO anus site histology

2.603 NZ WHO appendix primary histology

2.604 NZ WHO appendix site histology

2.605 NZ WHO biliary tract primary histology

2.606 NZ WHO biliary tract site histology

2.607 NZ WHO urinary bladder primary histology

2.608 NZ WHO urinary bladder site histology

2.609 NZ WHO bone histology

2.610 NZ WHO bone primary histology

2.611 NZ WHO breast benign histology

2.612 NZ WHO breast epithelial histology

2.613 NZ WHO breast fibroepithelial tumour and/or hamartoma histology

2.614 NZ WHO breast haematolymphoid histology

2.615 NZ WHO breast ductal carcinoma in situ histology

2.616 NZ WHO breast invasive carcinoma histology

2.617 NZ WHO breast invasive histology

2.618 NZ WHO male breast histology

2.619 NZ WHO breast mesenchymal histology

2.620 NZ WHO breast neuroendocrine histology

2.621 NZ WHO breast tumour of nipple histology

2.622 NZ WHO breast primary histology

2.623 NZ WHO breast uncertain and/or borderline histology

2.624 NZ WHO central nervous system tumour grade reference set

2.625 NZ WHO colorectal primary histology

2.626 NZ WHO colorectal site histology

2.627 NZ WHO malignant differentiation excluding undifferentiated grade

2.628 NZ WHO digestive system anal canal histology

2.629 NZ WHO digestive system appendix histology

2.630 NZ WHO digestive system colon and/or rectum histology

2.631 NZ WHO digestive system colon and/or rectum hormone producing tumor histology

2.632 NZ WHO digestive system germ cell tumour histology

2.633 NZ WHO digestive system haematolymphoid histology

2.634 NZ WHO digestive system histology

2.635 NZ WHO digestive system hormone producing tumor histology

2.636 NZ WHO digestive system liver and/or intrahepatic bile duct histology

2.637 NZ WHO digestive system mucosal melanoma histology

2.638 NZ WHO digestive system pancreas histology

2.639 NZ WHO digestive system primary histology

2.640 NZ WHO digestive system small intestine and/or ampulla histology

2.641 NZ WHO fallopian tube primary histology

2.642 NZ WHO fallopian tube site histology

2.643 NZ WHO female breast primary (no nipple) histology

2.644 NZ WHO female genital fallopian tube histology

2.645 NZ WHO female genital germ cell histology

2.646 NZ WHO female genital gestational trophoblastic disease histology

2.647 NZ WHO female genital haematolymphoid histology

2.648 NZ WHO female genital histology

2.649 NZ WHO female genital melanocytic lesion histology

2.650 NZ WHO female genital mesenchymal tumour of lower genital tract histology

2.651 NZ WHO female genital neuroendocrine histology

2.652 NZ WHO female genital ovary histology

2.653 NZ WHO female genital peritoneum histology

2.654 NZ WHO female genital primary histology

2.655 NZ WHO female genital uterine cervix histology

2.656 NZ WHO female genital uterine corpus histology

2.657 NZ WHO female genital uterine ligament histology

2.658 NZ WHO female genital vagina histology

2.659 NZ WHO female genital vulva histology

2.660 NZ WHO gestational trophoblastic primary histology

2.661 NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology

2.662 NZ WHO haematolymphoid acute leukaemia histology

2.663 NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology

2.664 NZ WHO haematolymphoid acute lymphoblastic leukaemia histology

2.665 NZ WHO haematolymphoid T lymphoblastic leukemia histology

2.666 NZ WHO haematolymphoid acute myeloid leukaemia histology

2.667 NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology

2.668 New Zealand WHO haematolymphoid B cell lymphoid neoplasm histology

2.669 NZ WHO haematolymphoid B cell lymphoma histology

2.670 NZ WHO haematolymphoid Burkitt lymphoma histology

2.671 New Zealand WHO haematolymphoid Castleman disease histology

2.672 NZ WHO haematolymphoid chronic eosinophilic leukaemia histology

2.673 NZ WHO haematolymphoid chronic leukaemia histology

2.674 NZ WHO haematolymphoid chronic lymphocytic leukaemia/small lymphocytic lymphoma histology

2.675 NZ WHO haematolymphoid chronic myeloid leukaemia histology

2.676 NZ WHO haematolymphoid chronic neutrophilic leukaemia histology

2.677 NZ WHO haematolymphoid cutaneous mastocytosis histology

2.678 NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology

2.679 NZ WHO haematolymphoid diffuse large B cell lymphoma histology

2.680 NZ WHO haematolymphoid essential thrombocythaemia histology

2.681 NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology

2.682 NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology

2.683 NZ WHO haematolymphoid follicular lymphoma histology

2.684 NZ WHO haematolymphoid hairy cell leukaemia histology

2.685 NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology

2.686 NZ WHO hematolymphoid tumor histology

2.687 NZ WHO haematolymphoid Hodgkin lymphoma histology

2.688 NZ WHO classification of tumours haematolymphoid intestinal T-cell AND/OR natural killer cell lymphoid proliferation histology reference set

2.689 NZ WHO haematolymphoid leukaemia histology

2.690 NZ WHO haematolymphoid lymphoma histology

2.691 NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology

2.692 NZ WHO haematolymphoid mastocytosis histology

2.693 NZ WHO haematolymphoid mastocytosis other histology

2.694 NZ WHO haematolymphoid mantle cell lymphoma histology

2.695 NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology

2.696 NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology

2.697 NZ WHO haematolymphoid mediastinal large B cell lymphoma histology

2.698 NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology

2.699 NZ WHO haematolymphoid primary myelofibrosis histology

2.700 NZ WHO hematolymphoid myeloid proliferation or neoplasm histology

2.701 NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology

2.702 New Zealand WHO haematolymphoid myeloid proliferation or neoplasm other histology

2.703 NZ WHO haematolymphoid myeloid precursor lesion histology

2.704 NZ WHO haematolymphoid myeloma histology

2.705 NZ WHO haematology chronic myeloproliferative neoplasm histology

2.706 NZ WHO haematolymphoid marginal zone lymphoma histology

2.707 NZ WHO haematolymphoid non-Hodgkin lymphoma histology

2.708 NZ WHO haematolymphoid NK/T cell lymphoma histology

2.709 NZ WHO haematolymphoid plasma cell neoplasms and/or other diseases with paraproteins histology

2.710 NZ WHO haematolymphoid primary CNS lymphoma histology

2.711 NZ WHO haematolymphoid polycythaemia vera histology

2.712 NZ WHO haematolymphoid small lymphocytic lymphoma histology

2.713 NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology

2.714 NZ WHO haematolymphoid systemic mastocytosis histology

2.715 NZ WHO haematolymphoid systemic mastocytosis histology

2.716 NZ WHO haematolymphoid T-cell AND/OR natural killer cell neoplasm other histology

2.717 NZ WHO heart primary histology

2.718 NZ WHO hepatopancreaticobiliary primary histology

2.719 NZ WHO haematolymphoid chronic lymphocytic leukaemia histology

2.720 NZ WHO haematolymphoid dendritic cell neoplasm histology

2.721 NZ WHO histology

2.722 NZ WHO haematolymphoid indolent B cell lymphoma other histology

2.723 NZ WHO haematolymphoid indolent B cell lymphoma histology

2.724 NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology

2.725 NZ WHO kidney primary histology

2.726 NZ WHO kidney site histology

2.727 NZ WHO liver primary histology

2.728 NZ WHO liver site histology

2.729 NZ WHO lower gastrointestinal primary histology

2.730 NZ WHO lower gastrointestinal site histology

2.731 NZ WHO lung primary histology

2.732 NZ WHO lung site histology

2.733 NZ WHO male breast primary histology

2.734 NZ WHO male breast primary (no nipple) histology

2.735 NZ WHO male genital primary histology

2.736 NZ WHO male genital site histology

2.737 NZ WHO haematolymphoid mature T cell and/or natural killer cell neoplasm histology

2.738 NZ WHO haematolymphoid mature T-cell AND/OR natural killer cell neoplasm other histology

2.739 NZ WHO medical oncology histology

2.740 NZ WHO medical oncology primary histology

2.741 NZ WHO neuroendocrine tumour grade

2.742 NZ WHO oesophagus primary histology

2.743 NZ WHO oesophagus site histology

2.744 NZ WHO ovarian germ cell primary histology

2.745 NZ WHO ovary site histology

2.746 NZ WHO pancreas primary histology

2.747 NZ WHO pancreas site histology

2.748 NZ WHO penis primary histology

2.749 NZ WHO penis site histology

2.750 NZ WHO pericardium site histology

2.751 NZ WHO peritoneum primary histology

2.752 NZ WHO peritoneum site histology

2.753 NZ WHO pleural primary histology

2.754 NZ WHO pleural site histology

2.755 NZ WHO prostate primary histology

2.756 NZ WHO prostate site histology

2.757 NZ WHO renal pelvis and/or ureter site histology

2.758 NZ WHO small intestine primary histology

2.759 NZ WHO small intestine site histology

2.760 NZ WHO soft tissue and/or bone histology

2.761 NZ WHO soft tissue and/or bone primary histology

2.762 NZ WHO soft tissue and/or bone undifferentiated small round cell sarcoma histology

2.763 NZ WHO soft tissue histology

2.764 NZ WHO soft tissue site histology

2.765 NZ WHO stomach primary histology

2.766 NZ WHO stomach site histology

2.767 NZ WHO testicular adnexa primary histology

2.768 NZ WHO testicular adnexa site histology

2.769 NZ WHO testicular other primary histology

2.770 NZ WHO testicular seminoma primary histology

2.771 NZ WHO testis primary histology

2.772 NZ WHO testis site histology

2.773 NZ WHO thoracic mediastinum haematolymphoid histology

2.774 NZ WHO thoracic heart histology

2.775 NZ WHO thoracic histology

2.776 NZ WHO thoracic lung histology

2.777 NZ WHO thoracic mesenchymal thorax histology

2.778 NZ WHO thoracic non small cell lung histology

2.779 NZ WHO thoracic pleura and/or pericardium histology

2.780 NZ WHO thoracic small cell lung histology

2.781 NZ WHO thoracic thymus histology

2.782 NZ WHO thymus primary histology

2.783 NZ WHO upper gastrointestinal primary histology

2.784 NZ WHO upper gastrointestinal site histology

2.785 NZ WHO urethra primary histology

2.786 NZ WHO urethra site histology

2.787 NZ WHO urinary and/or male genital haematolymphoid histology

2.788 NZ WHO urinary and/or male genital kidney histology

2.789 NZ WHO urinary and/or male genital melanocytic lesion histology

2.790 NZ WHO urinary and/or male genital mesenchymal histology

2.791 NZ WHO urinary and/or male genital neuroendocrine histology

2.792 NZ WHO urinary and/or male genital penis and/or scrotum histology

2.793 NZ WHO urinary and/or male genital primary histology

2.794 NZ WHO urinary and/or male genital prostate histology

2.795 NZ WHO urinary and/or male genital seminal vesicle histology

2.796 NZ WHO urinary and/or male genital testicular adnexa histology

2.797 NZ WHO urinary and/or male genital testis germ cell histology

2.798 NZ WHO urinary and/or male genital testis histology

2.799 NZ WHO urinary and/or male genital urinary tract histology

2.800 NZ WHO urinary system primary histology

2.801 NZ WHO urinary system site histology

2.802 NZ WHO uterine cervix primary histology

2.803 NZ WHO uterine cervix site histology

2.804 NZ WHO uterine corpus primary histology

2.805 NZ WHO uterine corpus site histology

2.806 NZ WHO uterine ligament primary histology

2.807 NZ WHO uterine ligament site histology

2.808 NZ WHO vagina primary histology

2.809 NZ WHO vagina site histology

2.810 NZ WHO vulva primary histology

2.811 NZ WHO vulva site histology

2.812 NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition)

2.813 NZ WHO bone histology (5th edition)

2.814 NZ WHO breast behaviour free histology (5th edition)

2.815 NZ WHO breast benign histology (5th edition)

2.816 NZ WHO breast fibroepithelial tumour and/or hamartoma histology (5th edition)

2.817 NZ WHO breast histology (5th edition)

2.818 NZ WHO breast ductal carcinoma in situ histology (5th edition)

2.819 NZ WHO breast invasive carcinoma histology (5th edition)

2.820 NZ WHO breast invasive histology (5th edition)

2.821 NZ WHO male breast histology (5th edition)

2.822 NZ WHO breast mesenchymal histology (5th edition)

2.823 NZ WHO breast tumour of nipple histology (5th edition)

2.824 NZ WHO breast uncertain and/or borderline histology (5th edition)

2.825 NZ WHO (5th edition) central nervous system tumour grade

2.826 NZ WHO (5th edition) malignant differentiation excluding undifferentiated grade

2.827 NZ WHO (5th edition) malignant differentiation grade

2.828 NZ WHO digestive system anal canal histology (5th edition)

2.829 NZ WHO digestive system appendix histology (5th edition)

2.830 NZ WHO digestive system colon and/or rectum hormone producing tumor histology (5th edition)

2.831 NZ WHO digestive system germ cell tumour histology (5th edition)

2.832 NZ WHO digestive system haematolymphoid histology (5th edition)

2.833 NZ WHO digestive system hormone producing tumor histology (5th edition)

2.834 NZ WHO digestive system liver and/or intrahepatic bile duct histology (5th edition)

2.835 NZ WHO digestive system mucosal melanoma histology (5th edition)

2.836 NZ WHO digestive system oesophagus histology (5th edition)

2.837 NZ WHO digestive system pancreas histology (5th edition)

2.838 NZ WHO digestive system small intestine and/or ampulla histology (5th edition)

2.839 NZ WHO digestive system stomach histology (5th edition)

2.840 NZ WHO female genital fallopian tube histology (5th edition)

2.841 NZ WHO female genital germ cell histology (5th edition)

2.842 NZ WHO female genital haematolymphoid histology (5th edition)

2.843 NZ WHO female genital histology (5th edition)

2.844 NZ WHO female genital melanocytic lesion histology (5th edition)

2.845 NZ WHO female genital mesenchymal tumour of lower genital tract histology (5th edition)

2.846 NZ WHO female genital neuroendocrine histology (5th edition)

2.847 NZ WHO female genital ovary histology (5th edition)

2.848 NZ WHO female genital uterine cervix histology (5th edition)

2.849 NZ WHO female genital uterine corpus histology (5th edition)

2.850 NZ WHO female genital vagina histology (5th edition)

2.851 NZ WHO female genital vulva histology (5th edition)

2.852 NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition)

2.853 NZ WHO haematolymphoid acute leukaemia histology (5th edition)

2.854 NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology (5th edition)

2.855 NZ WHO haematolymphoid acute lymphoblastic leukaemia histology (5th edition)

2.856 NZ WHO haematolymphoid T lymphoblastic leukemia histology (5th edition)

2.857 NZ WHO haematolymphoid acute myeloid leukaemia histology (5th edition)

2.858 NZ WHO haematolymphoid amyloidosis histology (5th edition)

2.859 NZ WHO haematolymphoid B cell lymphoid proliferation or lymphoma histology (5th edition)

2.860 NZ WHO haematolymphoid B cell lymphoma histology (5th edition)

2.861 NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition)

2.862 NZ WHO haematolymphoid chronic leukaemia histology (5th edition)

2.863 NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition)

2.864 NZ WHO haematolymphoid diffuse large B cell lymphoma histology (5th edition)

2.865 NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition)

2.866 NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition)

2.867 NZ WHO haematolymphoid follicular lymphoma histology (5th edition)

2.868 NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition)

2.869 NZ WHO haematolymphoid tumour histology (5th edition)

2.870 NZ WHO haematolymphoid Hodgkin lymphoma histology (5th edition)

2.871 NZ WHO haematolymphoid leukaemia histology (5th edition)

2.872 NZ WHO haematolymphoid lymphoma histology (5th edition)

2.873 NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition)

2.874 NZ WHO haematolymphoid mastocytosis histology (5th edition)

2.875 NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition)

2.876 NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition)

2.877 NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition)

2.878 NZ WHO haematolymphoid primary myelofibrosis histology (5th edition)

2.879 NZ WHO haematolymphoid myeloid proliferation or neoplasm histology (5th edition)

2.880 NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition)

2.881 NZ WHO haematolymphoid myeloid precursor lesion histology (5th edition)

2.882 NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition)

2.883 NZ WHO haematolymphoid marginal zone lymphoma histology (5th edition)

2.884 NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition)

2.885 NZ WHO haematolymphoid NK/T cell lymphoma histology (5th edition)

2.886 NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition)

2.887 NZ WHO haematolymphoid plasma cell neoplasms and/or other diseases with paraproteins histology (5th edition)

2.888 NZ WHO haematolymphoid primary CNS lymphoma histology (5th edition)

2.889 NZ WHO haematolymphoid polycythaemia vera histology (5th edition)

2.890 NZ WHO haematolymphoid small lymphocytic lymphoma histology (5th edition)

2.891 NZ WHO haematolymphoid stroma derived neoplasm of lymphoid tissue histology (5th edition)

2.892 NZ WHO haematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology (5th edition)

2.893 NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition)

2.894 NZ WHO haematolymphoid dendritic cell neoplasm histology (5th edition)

2.895 NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition)

2.896 NZ WHO (5th edition) malignant low high grade

2.897 NZ WHO haematolymphoid mature T cell and/or natural killer cell neoplasm histology (5th edition)

2.898 NZ WHO (5th edition) neuroendocrine tumour grade

2.899 NZ WHO soft tissue and/or bone undifferentiated small round cell sarcoma histology (5th edition)

2.900 NZ WHO thoracic ectopic tumour of thyroid and/or parathyroid origin histology (5th edition)

2.901 NZ WHO thoracic mediastinum germ cell histology (5th edition)

2.902 NZ WHO thoracic mediastinum haematolymphoid histology (5th edition)

2.903 NZ WHO thoracic heart histology (5th edition)

2.904 NZ WHO thoracic histology (5th edition)

2.905 NZ WHO thoracic lung histology (5th edition)

2.906 NZ WHO thoracic non small cell lung histology (5th edition)

2.907 NZ WHO thoracic small cell lung histology (5th edition)

2.908 NZ WHO urinary and/or male genital haematolymphoid histology (5th edition)

2.909 NZ WHO urinary and/or male genital histology (5th edition)

2.910 NZ WHO urinary and/or male genital kidney histology (5th edition)

2.911 NZ WHO urinary and/or male genital melanocytic lesion histology (5th edition)

2.912 NZ WHO urinary and/or male genital mesenchymal histology (5th edition)

2.913 NZ WHO urinary and/or male genital neuroendocrine histology (5th edition)

2.914 NZ WHO urinary and/or male genital penis and/or scrotum histology (5th edition)

2.915 NZ WHO urinary and/or male genital prostate histology (5th edition)

2.916 NZ WHO urinary and/or male genital seminal vesicle histology (5th edition)

2.917 NZ WHO urinary and/or male genital testicular adnexa histology (5th edition)

2.918 NZ WHO urinary and/or male genital testis histology (5th edition)

2.919 NZ WHO urinary and/or male genital urinary tract histology (5th edition)

2.920 NZ Citizenship status

2.921 Condition Clinical Status Codes

2.922 Problem Severity - IPS

2.923 Condition/Diagnosis Severity

2.924 ConditionVerificationStatus

2.925 ContactPoint purpose

2.926 COVID19 Antiviral eligibility criteria

2.927 Current Smoking Status - IPS

2.928 Number of cord vessels

2.929 Datum code

2.930 AIR indication code

2.931 District Health Board Identifer

2.932 DocumentMode

2.933 Death date Information Source

2.934 Domicile Code

2.935 AIR body site

2.936 Pregnancy Expected Delivery Date Method - IPS

2.937 NZ ethnic group code level 1

2.938 NZ ethnic group code level 2

2.939 NZ ethnic group code level 3

2.940 Ethnicity of a person

2.941 Funded Programme

2.942 General dentistry diagnostic codes

2.943 Healthcare Professional Roles - IPS

2.944 Health NZ language Value Set

2.945 PractitionerRole status reason

2.946 Information Source

2.947 ISO 639 2 and 3 language codes

2.948 ISO 3166-1 alpha-2 country codes

2.949 Iwi

2.950 Alias types

2.951 MedDRA LLT 26.0 VS

2.952 MedDRA LLT 27.0 VS

2.953 MedDRA

2.954 Medications - SNOMED CT + Absent/Unknown (IPS)

2.955 Medicine Doseform - IPS

2.956 Medicine Route of Administration - IPS

2.957 NZ Residency status

2.958 NZMT - CTPP

2.959 NZMT MP (SPS)

2.960 NZMT - MP

2.961 NZMT - MPP

2.962 NZMT - MPUU

2.963 NZMT - TP

2.964 NZMT - TPP

2.965 NZMT - TPUU

2.966 NZMT Concept Type

2.967 NZPOCS

2.968 LOINC Codes

2.969 Vital Signs

2.970 PHO

2.971 Registration Status of Practitioners

2.972 Scope of practice

2.973 Pregnancies Summary - IPS

2.974 Pregnancy Status - IPS

2.975 Problem Type (LOINC)

2.976 Problem Type - IPS

2.977 Problems - SNOMED CT + Absent/Unknown - IPS

2.978 Problems (SNOMED CT) - IPS

2.979 Procedures - SNOMED CT + Absent/Unknown - IPS

2.980 Procedures (SNOMED CT) - IPS

2.981 NZ purpose of use

2.982 AllergyIntoleranceSeverity

2.983 SNOMED CT Drug Therapy Status codes

2.984 Results Coded Values Pathology - IPS

2.985 Results Blood Group - IPS

2.986 Results Coded Values Laboratory - IPS

2.987 Results Laboratory Observation - IPS

2.988 Results Microorganism - IPS

2.989 Results Pathology Observation - IPS

2.990 Results Radiology Measurement Observation (SNOMED-DICOM) - IPS

2.991 Results Radiology Observation - IPS

2.992 Results Radiology Textual Observations (SNOMED-DICOM-LOINC) - IPS

2.993 Results Specimen Type - IPS

2.994 Vaccine Target Diseases - IPS

2.995 Target Site - IPS

2.996 Common UCUM units

2.997 Vital Signs Units

2.998 UKPUL

2.999 Vaccine Administered Value Set

2.1000 Vaccines - IPS

2.1001 Clinical code type code

2.1002 Admission type code

2.1003 Agency type code

2.1004 Uterotonic drugs administered status code

2.1005 Infant feeding method code

2.1006 Clinical coding system code

2.1007 Domicile Code

2.1008 Number of cord vessels code

2.1009 DSM-IV

2.1010 Temporary rheumatic fever codes

2.1011 Antiviral eligibility - criteria codes

2.1012 Antiviral eligibility - when symptoms started codes

2.1013 Vaccine Administered Code Set (CVX)

2.1014 NZ ethnic group codes

2.1015 ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code

2.1016 Rheumatic fever diagnostic certainty

2.1017 Oral health enrolment termination reason code

2.1018 Type of Alias

2.1019 AllergyIntolerance Clinical Status Codes

2.1020 ANZSCO

2.1021 AIR legacy codes

2.1022 canshare-test-nonsnomed

2.1023 Canshare testing non-snomed concepts

2.1024 Concepts that are not yet formally published

2.1025 Coverage category

2.1026 Coverage type

2.1027 NZ Purpose Of Use

2.1028 Datum codes

2.1029 NZ DHB

2.1030 Skin to skin end reason

2.1031 EDQM - Standard Terms

2.1032 Level 4 ethnicity codes

2.1033 NZVX immunisation codes

2.1034 Admission source code

2.1035 PractitionerRole status reason

2.1036 ISO 639-2 Language Codes Alpha 3

2.1037 ISO 639-3 Language Codes Alpha 3

2.1038 NZ Iwi

2.1039 LOINC_NZ_local_code

2.1040 Māori descent codes

2.1041 MedDRA LLT 26.0 CS

2.1042 MedDRA LLT 27.0 CS

2.1043 Medication status codes

2.1044 MyDocumentMode

2.1045 MyNewCS

2.1046 PHO

2.1047 Additional Authorisation

2.1048 Scope of practice

2.1049 Omaha System CodeSystem

2.1050 v3 Code System ActReason

2.1051 Unified Code for Units of Measure (UCUM)